University of Basel - ECPM

Master Course of Advanced Studies in Medicines Development (MMD)

Practical Information

Commencing Date :
Language :
Location :
Basel Switzerland

Teaching Methodology :
Blended Learning

Scholarship Possibilities :

Course Contact

Annette Mollet

+41 61 267 19 52


Office Link

University of Basel - ECPM

University Accreditation : Yes

Centre of Excellence


The Master programme offers the possibility to obtain a postgraduate Master in Medicines Development (MMD) at the University of Basel both for physicians as well as all other pharmaceutical professionals concerned with the development of medicines from molecule to market place. The MMD programme extends the six modules of the Dimploma Course. The MMD programme is targeted at representatives from industry, service industry, academic and government decision- and policy-makers who already have a good grounding in the basics of drug development and will benefit from a more in-depth, comprehensive and systematic immersion into modern medical product development, regulation and market introduction. The programme is designed and organised by the European Center of Pharmaceutical Medicine ECPM together with other Universities throughout Europe and other health care partner organisations. ECPM collaborates with a science-driven and highly experienced international Faculty including a network of experts in pharmaceutical medicine and medical product development sciences. The master modules are offered by a network of universities under the quality label of Pharmatrain ( The MDD is composed of three parts (60 ECTS): The ECPM Diploma Course (6 modules, triple-exam, 30ECTS) Master Modules (20 ECTS)* Master Thesis (10 ECTS)* *can be taken individually or in parallel to the ECPM Course

Covered Areas

Scientific Areas

PK/PD modelling Production technologies Target discovery and lead selection

IMI Standards

  • A predefined set of teaching objectives, leading to defined learning outcomes
  • Assessment of the students' achievement in accordance with the agreed learning outcomes of the training offered
  • A system for collecting, assessing and addressing feedback from learners, teachers, technical / administrative staff and programme / course / module managers
  • Availability of appropriate and regularly reviewed reference material (e.g. published articles, links, book chapters, scripts, etc)
  • Defined and transparent admission criteria
  • Quality assurance of teaching staff
  • Regular review of the QA/QC process and demonstration that the training is further developed in light of this review
  • The facilities, infrastructure, leadership and competences available for the support of student learning
  • University accreditation OR a system for approving, monitoring and reviewing the training offered


Module Title





Disease Biology-Based Pharmacology Core 3.0 ECTS No
Translational Science and Pharmacology Core 2.0 ECTS No
Drug Safety and Pharmacovigilance: E-Learning Core 1.0 ECTS
Essentials of Clinical Study Management Core 1.0 ECTS No
Pharmacoepidemiology Core 1.0 ECTS No
Basics in Health Economics: E-Learning Core Full Time 1.0 ECTS
Ethics and Regulation in Clinical Research Elective 1.0 ECTS No
Life Sciences Leadership and Business Strategies Core 3.0 ECTS No
Frontiers in Drug Development Elective Full Time 1.0 ECTS
Opening and Closing Presentations with POWER No
Scientific Medical Writing Elective 1.0 ECTS
BioBusiness Development Elective No